Evonik (EVK) Stock Forecast & Price Target

Compare

56 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

EVK Analyst Ratings

Moderate Buy

6 Buy

4 Hold

2 Sell

Based on 12 analysts giving stock ratings to

Evonik

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

EVK Stock 12 Month Forecast

Average Price Target

€21.59

▲(13.04%Upside)

Based on 12 Wall Street analysts offering 12 month price targets for Evonik in the last 3 months. The average price target is €21.59 with a high forecast of €25.00 and a low forecast of €17.80. The average price target represents a 13.04% change from the last price of €19.10.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"14":"€14","17":"€17","20":"€20","23":"€23","26":"€26"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":25,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">€25.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":21.59,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">€21.59</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":17.8,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">€17.80</span>\n  </div></div>","useHTML":true}}],"tickPositions":[14,17,20,23,26],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Sep<br/>2024","6":"Dec<br/>2024","9":"Mar<br/>2025","12":"Jun<br/>2025","25":"Jun<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,18.99,19.45230769230769,19.914615384615384,20.376923076923077,20.839230769230767,21.30153846153846,21.763846153846153,22.226153846153846,22.68846153846154,23.150769230769228,23.613076923076925,24.075384615384614,24.537692307692307,{"y":25,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,18.99,19.189999999999998,19.389999999999997,19.59,19.79,19.99,20.189999999999998,20.39,20.59,20.79,20.99,21.19,21.39,{"y":21.59,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,18.99,18.898461538461536,18.806923076923077,18.715384615384615,18.623846153846152,18.532307692307693,18.44076923076923,18.34923076923077,18.257692307692306,18.166153846153847,18.074615384615385,17.983076923076922,17.891538461538463,{"y":17.8,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":17.864,"date":1717200000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":17.781,"date":1719792000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 24,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 14, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":17.95,"date":1722470400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":18.925,"date":1725148800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 15, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":19.895,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":19.094,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":16.411,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":15.752,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":17.075,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":18.04,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":18.817,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":18.595,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 6</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":18.99,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 5</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target€25.00

Average Price Target€21.59

Lowest Price Target€17.80

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

TipRanks AITipRanks

Not Ranked

TipRanks

€20.5

Hold

7.33%

Upside

Reiterated

06/05/25

Evonik's overall stock score is driven primarily by stable cash flow and positive technical indicators, despite challenges in financial performance due to declining revenues and profitability. The high P/E ratio suggests a premium valuation, partially offset by a strong dividend yield. Technical indicators point to potential bullish momentum, which contributes significantly to the score.

Geoff HaireUBS

UBS

€19→€20

Hold

4.71%

Upside

Reiterated

06/05/25

UBS Sticks to Their Hold Rating for Evonik (0QDS)

Sebastian BrayBerenberg Bank

Berenberg Bank

€20

Hold

4.71%

Upside

Reiterated

06/03/25

Berenberg Bank Reaffirms Their Hold Rating on Evonik (0QDS)

Georgina Fraser CFAGoldman Sachs

Goldman Sachs

€18.9→€20

Hold

4.71%

Upside

Reiterated

05/29/25

Goldman Sachs Reaffirms Their Hold Rating on Evonik (0QDS)

Virginie Boucher-FerteDeutsche Bank

Deutsche Bank

€23→€25

Buy

30.89%

Upside

Reiterated

05/27/25

Deutsche Bank Remains a Buy on Evonik (0QDS)

Peter SpenglerDZ BANK AG

DZ BANK AG

―

Buy

―

Reiterated

05/23/25

DZ BANK AG Reaffirms Their Buy Rating on Evonik (0QDS)

Chetan UdeshiJ.P. Morgan

J.P. Morgan

€23.8

Buy

24.61%

Upside

Reiterated

05/23/25

J.P. Morgan Sticks to Its Buy Rating for Evonik (0QDS)

Chris CounihanJefferies

Jefferies

€18.8

Sell

-1.57%

Downside

Reiterated

05/22/25

Evonik (0QDS) Receives a Sell from Jefferies

Oliver SchwarzWarburg Research

Warburg Research

€25.4→€24.5

Buy

28.27%

Upside

Reiterated

05/21/25

Evonik (0QDS) Gets a Buy from Warburg Research

Martin RoedigerKepler Capital

Kepler Capital

€21.6

Hold

13.09%

Upside

Reiterated

05/20/25

Kepler Capital Sticks to Their Hold Rating for Evonik (0QDS)

Jonathan ChungMorgan Stanley

Morgan Stanley

€18.6→€17.8

Sell

-6.81%

Downside

Reiterated

05/13/25

Evonik Industries AG (EVK:GR) (EVKIF) PT Lowered to EUR17.80 at Morgan StanleyMorgan Stanley analyst Jonathan Chung lowered the price target on Evonik Industries AG (EVK:GR) (OTC: EVKIF) to EUR17.80 (from EUR18.60) while maintaining a Underweight rating.

Sebastian SatzCiti

Citi

€25→€23

Buy

20.42%

Upside

Reiterated

04/14/25

Evonik Industries AG (EVK:GR) (EVKIF) PT Lowered to EUR23 at CitiCiti analyst Sebastian Satz lowered the price target on Evonik Industries AG (EVK:GR) (OTC: EVKIF) to EUR23.00 (from EUR25.00) while maintaining a Buy rating.

Andreas HeineStifel Nicolaus

Stifel Nicolaus

€23

Buy

20.42%

Upside

Reiterated

03/18/25

Evonik's Strong Growth Potential and Resilience: A Buy Recommendation by Andreas Heine

Anil ShenoyBarclays

Barclays

€25

Buy

30.89%

Upside

Reiterated

09/06/24

Barclays Keeps Their Buy Rating on Evonik (0QDS)

Konstantin WiechertBaader Bank

Baader Bank

€17.5

Buy

-8.38%

Downside

Reiterated

06/24/24

Baader Bank Sticks to Its Buy Rating for Evonik (0QDS)

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

TipRanks AITipRanks

Not Ranked

TipRanks

€20.5

Hold

7.33%

Upside

Reiterated

06/05/25

Geoff HaireUBS

UBS

€19→€20

Hold

4.71%

Upside

Reiterated

06/05/25

UBS Sticks to Their Hold Rating for Evonik (0QDS)

Sebastian BrayBerenberg Bank

Berenberg Bank

€20

Hold

4.71%

Upside

Reiterated

06/03/25

Berenberg Bank Reaffirms Their Hold Rating on Evonik (0QDS)

Georgina Fraser CFAGoldman Sachs

Goldman Sachs

€18.9→€20

Hold

4.71%

Upside

Reiterated

05/29/25

Goldman Sachs Reaffirms Their Hold Rating on Evonik (0QDS)

Virginie Boucher-FerteDeutsche Bank

Deutsche Bank

€23→€25

Buy

30.89%

Upside

Reiterated

05/27/25

Deutsche Bank Remains a Buy on Evonik (0QDS)

Peter SpenglerDZ BANK AG

DZ BANK AG

―

Buy

―

Reiterated

05/23/25

DZ BANK AG Reaffirms Their Buy Rating on Evonik (0QDS)

Chetan UdeshiJ.P. Morgan

J.P. Morgan

€23.8

Buy

24.61%

Upside

Reiterated

05/23/25

J.P. Morgan Sticks to Its Buy Rating for Evonik (0QDS)

Chris CounihanJefferies

Jefferies

€18.8

Sell

-1.57%

Downside

Reiterated

05/22/25

Evonik (0QDS) Receives a Sell from Jefferies

Oliver SchwarzWarburg Research

Warburg Research

€25.4→€24.5

Buy

28.27%

Upside

Reiterated

05/21/25

Evonik (0QDS) Gets a Buy from Warburg Research

Martin RoedigerKepler Capital

Kepler Capital

€21.6

Hold

13.09%

Upside

Reiterated

05/20/25

Kepler Capital Sticks to Their Hold Rating for Evonik (0QDS)

Jonathan ChungMorgan Stanley

Morgan Stanley

€18.6→€17.8

Sell

-6.81%

Downside

Reiterated

05/13/25

Sebastian SatzCiti

Citi

€25→€23

Buy

20.42%

Upside

Reiterated

04/14/25

Andreas HeineStifel Nicolaus

Stifel Nicolaus

€23

Buy

20.42%

Upside

Reiterated

03/18/25

Evonik's Strong Growth Potential and Resilience: A Buy Recommendation by Andreas Heine

Anil ShenoyBarclays

Barclays

€25

Buy

30.89%

Upside

Reiterated

09/06/24

Barclays Keeps Their Buy Rating on Evonik (0QDS)

Konstantin WiechertBaader Bank

Baader Bank

€17.5

Buy

-8.38%

Downside

Reiterated

06/24/24

Baader Bank Sticks to Its Buy Rating for Evonik (0QDS)

Stocks with the Highest Top Analyst Consensus in the Industrials Sector

xxx

Find stocks in the Industrials sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Evonik

1 Month

xxx

Success Rate

16/21 ratings generated profit

Average Return

+3.28%

reiterated a xxx

rating 18 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 1 Month would result in 76.19% of your transactions generating a profit, with an average return of +3.28% per trade.

3 Months

xxx

Success Rate

15/21 ratings generated profit

Average Return

+4.63%

reiterated a xxx

rating 18 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 71.43% of your transactions generating a profit, with an average return of +4.63% per trade.

1 Year

Peter SpenglerDZ BANK AG

Success Rate

16/21 ratings generated profit

Average Return

+9.88%

reiterated a buy rating 18 days ago

Copying Peter Spengler's trades and holding each position for 1 Year would result in 76.19% of your transactions generating a profit, with an average return of +9.88% per trade.

2 Years

xxx

Success Rate

21/21 ratings generated profit

Average Return

+23.12%

reiterated a xxx

rating 18 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +23.12% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

EVK Analyst Recommendation Trends

Rating

Feb 25

Mar 25

Apr 25

May 25

Jun 25

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, EVK has received 10 Buy Ratings, 10 Hold Ratings, and 5 Sell Ratings. EVK average Analyst price target in the past 3 months is 21.59.

Each month's total comprises the sum of three months' worth of ratings.

EVK Financial Forecast

EVK Earnings Forecast

Next quarter’s earnings estimate for EVK is €0.46 with a range of €0.36 to €0.55. The previous quarter’s EPS was €0.59. EVK beat its EPS estimate 100.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 62.97% of the time in the same period. In the last calendar year EVK has Outperformed its overall industry.

EVK Sales Forecast

Next quarter’s sales forecast for EVK is €3.88B with a range of €3.64B to €4.08B. The previous quarter’s sales results were €3.78B. EVK beat its sales estimates 25.00% of the time in past 12 months, while its overall industry beat sales estimates 56.61% of the time in the same period. In the last calendar year EVK has Outperformed its overall industry.

EVK Stock Forecast FAQ

What is DE:EVK’s average 12-month price target, according to analysts?

Based on analyst ratings, Evonik’s 12-month average price target is 21.59.

What is DE:EVK’s upside potential, based on the analysts’ average price target?

Evonik has 13.04% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is Evonik a Buy, Sell or Hold?

Evonik has a consensus rating of Moderate Buy, which is based on 6 buy ratings, 4 hold ratings and 2 sell ratings.

What is Evonik’s share price target?

The average share price target for Evonik is 21.59. This is based on 12 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is €25.00 ,and the lowest forecast is €17.80. The average share price target represents 13.04% Increase from the current price of €19.1.

What do analysts say about Evonik?

Evonik’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 12 Wall Streets Analysts.

How can I buy shares of Evonik?

To buy shares of DE:EVK, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing

Evonik (EVK) Stock Forecast & Price Target

EVK Analyst Ratings

EVK Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Evonik

EVK Analyst Recommendation Trends

EVK Financial Forecast

EVK Earnings Forecast

EVK Sales Forecast

EVK Stock Forecast FAQ

Become an Expert with TipRanks Premium

Detailed List of Analyst Forecasts